HCP
NVAX icon

Hexagon Capital Partners’s Novavax NVAX Stock Holding History

Hexagon Capital Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38
Closed -$275 – 1478
2023
Q3 		$275 Sell
38
-12
-24% -$96 ﹤0.01% 1321
2023
Q2 		$372 Sell
50
-2
-4% -$16 ﹤0.01% 1305
2023
Q1 		$360 Sell
52
-189
-78% -$1.74K ﹤0.01% 1312
2022
Q4 		$2.48K Sell
241
-152
-39% -$2.68K ﹤0.01% 1050
2022
Q3 		$7K Buy
+393
New +$17K ﹤0.01% 859

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hexagon Capital Partners's NVAX Position: Q4 2023 in Review

Hexagon Capital Partners sold out of Novavax (NVAX) in Q4 2023, closing a stake of 38 shares — an estimated $275 sold.

Hexagon Capital Partners first reported a position in NVAX in Q3 2022 and held it in 5 quarters. The position peaked at $7K in Q3 2022. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • Hexagon Capital Partners reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • Hexagon Capital Partners sold 38 Novavax shares in Q4 2023, an estimated $275.
  • Hexagon Capital Partners first reported a position in Novavax in Q3 2022 and held it in 5 quarters.
  • Hexagon Capital Partners's Novavax position peaked at $7K in Q3 2022.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Hexagon Capital Partners's 13F filing for Q4 2023, filed 5 Feb 2024.